SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000891554-02-000041
Filing Date
2002-01-07
Accepted
2002-01-07 00:00:00
Documents
4
Group Members
AVENTIS HOLDINGS INCAVENTIS PHARMACEUTICALS INC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d27625_sc13d.txt SC 13D 27237
3 DIRECTORS AND OFFICERS d27625_ex99-1.txt EX-99.1 8237
4 INFORMATION RELATING TO DIR. AND EXE. OFFICERS d27625_ex99-2.txt EX-99.2 5177
5 AGREEMENT TO FILE JOINTLY d27625_ex99-3.txt EX-99.3 1122
  Complete submission text file 0000891554-02-000041.txt   44261
Mailing Address
Business Address 500 ARCOLA RD P O BOX 1200 M/S 5B14 COLLEGEVILLE PA 19426-0107 6104548000
RHONE POULENC RORER INC (Filed by) CIK: 0000217028 (see all company filings)

IRS No.: 231699163 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-47221 | Film No.: 2503300
SIC: 2836 Biological Products, (No Diagnostic Substances)